UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000033892 |
|---|---|
| Receipt number | R000038656 |
| Scientific Title | A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation |
| Date of disclosure of the study information | 2019/12/02 |
| Last modified on | 2023/03/24 10:00:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation
Acronym
A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation
Scientific Title
A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation
Scientific Title:Acronym
A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation
Region
| Japan |
Condition
Condition
Healthy Volunteers
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effects of imidazole dipeptides on improving fatigue sensation: a randomized, double-blind, placebo-controlled, crossover study
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
VAS (fatigue sensation)
Key secondary outcomes
Chalder fatigue scale, T score of "fatigue-inertia" in subscale of POMS2 short version, Performance test (10-second high power test) after 4-week intake
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Intake of test food for 4 weeks -> Washout for 4 weeks -> Intake of Placebo for 4 weeks
Interventions/Control_2
Intake of Placebo for 4 weeks -> Washout for 4 weeks -> Intake of test food for 4 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1) Subjects whose age of 40 years or more and less than 65 years
2) Subjects who were evaluated 40 or more in T score of "fatigue-inertia" in subscale of POMS2 short version
3) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntary participate in the study and being able to personally sign a written informed consent
Key exclusion criteria
1) Subjects receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders
2) Subjects having the chronic fatigue syndrome (CFS), or subjects deemed to have severe fatigue like idiopathic chronic fatigue by the investigator
3) Subjects having a medical history of chest pain or syncope
4) Subjects deemed unsuitable in the electrocardiogram by the investigator
5) Subjects having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations
6) Subjects who have the possibility of developing allergic symptoms by the test food
7) Subjects who take regularly pharmaceuticals or quasi-drugs which having the efficacy for recovery from fatigue or nutrient replenishment in case of physical fatigue
8) Subjects who take regularly supplements of protein or amino acid drink
9) Subjects who take regularly Foods with Function Claims labeled the effect of attenuating fatigue sensation
10) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood)
11) Subjects who took part in another clinical study within 1 month prior to the start of the present study or who is currently taking part in another clinical study
12) Female subjects who are pregnant or lactating, or intending to become pregnant during the study
13) Subjects deemed unsuitable by the investigator
Target sample size
12
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mikako Sato |
Organization
NH Foods Ltd.
Division name
R&D Center
Zip code
Address
3-3 Midorigahara, Tsukuba, Ibaraki
TEL
029-847-7815
m.satou@nipponham.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Tomohiro Sugino |
Organization
Soiken Inc.
Division name
Representative Director
Zip code
Address
Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka
TEL
06-6871-8888
Homepage URL
sugino@soiken.com
Sponsor or person
Institute
Soiken Inc.
Institute
Department
Personal name
Funding Source
Organization
NH Foods Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 12 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 08 | Month | 18 | Day |
Date of IRB
| 2018 | Year | 08 | Month | 18 | Day |
Anticipated trial start date
| 2018 | Year | 08 | Month | 25 | Day |
Last follow-up date
| 2018 | Year | 12 | Month | 02 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 08 | Month | 25 | Day |
Last modified on
| 2023 | Year | 03 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038656
